Pharmacokinetics of Leritrelvir(RAY1216) in Participants With Severe Kidney Disease

NCT06160622 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Impairment

Interventions

DRUG: Leritrelvir

Sponsor

Guangdong Raynovent Biotech Co., Ltd